ITMI20041295A1 - Composizioni farmaceutiche antimicrobiche orali - Google Patents

Composizioni farmaceutiche antimicrobiche orali

Info

Publication number
ITMI20041295A1
ITMI20041295A1 IT001295A ITMI20041295A ITMI20041295A1 IT MI20041295 A1 ITMI20041295 A1 IT MI20041295A1 IT 001295 A IT001295 A IT 001295A IT MI20041295 A ITMI20041295 A IT MI20041295A IT MI20041295 A1 ITMI20041295 A1 IT MI20041295A1
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
oral anti
microbial pharmaceutical
microbial
oral
Prior art date
Application number
IT001295A
Other languages
English (en)
Inventor
Mauro Ajani
Roberta Bozzella
Giuseppe Celasco
Roberto Villa
Original Assignee
Cosmo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo Spa filed Critical Cosmo Spa
Priority to IT001295A priority Critical patent/ITMI20041295A1/it
Publication of ITMI20041295A1 publication Critical patent/ITMI20041295A1/it
Priority to CA2569683A priority patent/CA2569683C/en
Priority to RSP-2008/0241A priority patent/RS50581B/sr
Priority to KR1020067027024A priority patent/KR101157486B1/ko
Priority to CNA2008101001129A priority patent/CN101317826A/zh
Priority to JP2007517234A priority patent/JP5026262B2/ja
Priority to MXPA06014698A priority patent/MXPA06014698A/es
Priority to ES05749954T priority patent/ES2303255T3/es
Priority to DE602005006278T priority patent/DE602005006278T2/de
Priority to SI200530254T priority patent/SI1763339T1/sl
Priority to AT05749954T priority patent/ATE392889T1/de
Priority to CA002628005A priority patent/CA2628005A1/en
Priority to ZA200610577A priority patent/ZA200610577B/en
Priority to CN2005800206291A priority patent/CN1976685B/zh
Priority to PCT/EP2005/052025 priority patent/WO2006003043A1/en
Priority to PT05749954T priority patent/PT1763339E/pt
Priority to PL05749954T priority patent/PL1763339T3/pl
Priority to US11/571,044 priority patent/US8486446B2/en
Priority to DK05749954T priority patent/DK1763339T3/da
Priority to KR1020087012947A priority patent/KR20080059337A/ko
Priority to EP05749954A priority patent/EP1763339B1/en
Priority to EP07122775A priority patent/EP1894560A1/en
Priority to JP2008039159A priority patent/JP2008163038A/ja
Priority to US12/133,568 priority patent/US20080233193A1/en
Priority to HR20080252T priority patent/HRP20080252T3/xx
Priority to CY20081100739T priority patent/CY1108196T1/el
Priority to US13/451,111 priority patent/US8263120B2/en
Priority to US13/592,097 priority patent/US20120316229A1/en
Priority to US13/592,088 priority patent/US8741948B2/en
Priority to US13/616,582 priority patent/US8529945B2/en
Priority to US14/471,509 priority patent/US20140370093A1/en
Priority to US16/289,748 priority patent/US20190192441A1/en
Priority to FIC20190031C priority patent/FIC20190031I1/fi
Priority to HUS1900037C priority patent/HUS1900037I1/hu
Priority to US17/114,057 priority patent/US20210093576A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IT001295A 2004-06-25 2004-06-25 Composizioni farmaceutiche antimicrobiche orali ITMI20041295A1 (it)

Priority Applications (35)

Application Number Priority Date Filing Date Title
IT001295A ITMI20041295A1 (it) 2004-06-25 2004-06-25 Composizioni farmaceutiche antimicrobiche orali
EP07122775A EP1894560A1 (en) 2004-06-25 2005-05-03 Oral antimicrobial pharmaceutical compositions comprising metronidazole
PL05749954T PL1763339T3 (pl) 2004-06-25 2005-05-03 Antybakteryjne, doustne kompozycje farmaceutyczne
DK05749954T DK1763339T3 (da) 2004-06-25 2005-05-03 Orale antimikrobielle farmaceutiske præparater
KR1020067027024A KR101157486B1 (ko) 2004-06-25 2005-05-03 경구용 항미생물성 제약학적 조성물
CNA2008101001129A CN101317826A (zh) 2004-06-25 2005-05-03 口服抗微生物药物组合物
US11/571,044 US8486446B2 (en) 2004-06-25 2005-05-03 Oral antimicrobial pharmaceutical compositions
MXPA06014698A MXPA06014698A (es) 2004-06-25 2005-05-03 Composiciones farmaceuticas antimicrobianas orales.
ES05749954T ES2303255T3 (es) 2004-06-25 2005-05-03 Composiciones farmaceuticas antimicrobianas orales.
RSP-2008/0241A RS50581B (sr) 2004-06-25 2005-05-03 Oralne antimikrobijalne farmaceutske kompozicije
SI200530254T SI1763339T1 (sl) 2004-06-25 2005-05-03 Oralni antimikrobni farmacevtski sestavki
KR1020087012947A KR20080059337A (ko) 2004-06-25 2005-05-03 경구용 항미생물성 제약학적 조성물
CA002628005A CA2628005A1 (en) 2004-06-25 2005-05-03 Oral antimicrobial pharmaceutical compositions
ZA200610577A ZA200610577B (en) 2004-06-25 2005-05-03 Oral antimicrobal pharmaceutical compositions
CN2005800206291A CN1976685B (zh) 2004-06-25 2005-05-03 口服抗微生物药物组合物
PCT/EP2005/052025 WO2006003043A1 (en) 2004-06-25 2005-05-03 Oral antimicrobial pharmceutical compositions
PT05749954T PT1763339E (pt) 2004-06-25 2005-05-03 Composições farmacêuticas orais antimicrobianas
CA2569683A CA2569683C (en) 2004-06-25 2005-05-03 Oral antimicrobial pharmaceutical compositions
JP2007517234A JP5026262B2 (ja) 2004-06-25 2005-05-03 経口抗菌医薬組成物
DE602005006278T DE602005006278T2 (de) 2004-06-25 2005-05-03 Orale antimikrobielle pharmazeutische zusammensetzungen
AT05749954T ATE392889T1 (de) 2004-06-25 2005-05-03 Orale antimikrobielle pharmazeutische zusammensetzungen
EP05749954A EP1763339B1 (en) 2004-06-25 2005-05-03 Oral antimicrobial pharmceutical compositions
JP2008039159A JP2008163038A (ja) 2004-06-25 2008-02-20 経口抗菌医薬組成物
US12/133,568 US20080233193A1 (en) 2004-06-25 2008-06-05 Oral antimicrobial pharmaceutical compositions
HR20080252T HRP20080252T3 (en) 2004-06-25 2008-06-09 Oral antimicrobial pharmaceutical compositions
CY20081100739T CY1108196T1 (el) 2004-06-25 2008-07-14 Αντιμικροβιακες φαρμακευτικες συνθεσεις χορηγουμενες απο το στομα
US13/451,111 US8263120B2 (en) 2004-06-25 2012-04-19 Oral antimicrobial pharmaceutical compositions
US13/592,088 US8741948B2 (en) 2004-06-25 2012-08-22 Oral antimicrobial pharmaceutical compositions
US13/592,097 US20120316229A1 (en) 2004-06-25 2012-08-22 Oral antimicrobial pharmaceutical compositions
US13/616,582 US8529945B2 (en) 2004-06-25 2012-09-14 Oral antimicrobial pharmaceutical compositions
US14/471,509 US20140370093A1 (en) 2004-06-25 2014-08-28 Oral antimicrobial pharmaceutical compositions
US16/289,748 US20190192441A1 (en) 2004-06-25 2019-03-01 Oral antimicrobial pharmaceutical compositions
FIC20190031C FIC20190031I1 (fi) 2004-06-25 2019-05-28 Rifamysiini SV
HUS1900037C HUS1900037I1 (hu) 2004-06-25 2019-07-08 Orális mikrobaellenes gyógyszerészeti kompozíciók
US17/114,057 US20210093576A1 (en) 2004-06-25 2020-12-07 Oral antimicrobial pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001295A ITMI20041295A1 (it) 2004-06-25 2004-06-25 Composizioni farmaceutiche antimicrobiche orali

Publications (1)

Publication Number Publication Date
ITMI20041295A1 true ITMI20041295A1 (it) 2004-09-25

Family

ID=34968899

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001295A ITMI20041295A1 (it) 2004-06-25 2004-06-25 Composizioni farmaceutiche antimicrobiche orali

Country Status (22)

Country Link
US (9) US8486446B2 (it)
EP (2) EP1894560A1 (it)
JP (2) JP5026262B2 (it)
KR (2) KR101157486B1 (it)
CN (2) CN1976685B (it)
AT (1) ATE392889T1 (it)
CA (2) CA2628005A1 (it)
CY (1) CY1108196T1 (it)
DE (1) DE602005006278T2 (it)
DK (1) DK1763339T3 (it)
ES (1) ES2303255T3 (it)
FI (1) FIC20190031I1 (it)
HR (1) HRP20080252T3 (it)
HU (1) HUS1900037I1 (it)
IT (1) ITMI20041295A1 (it)
MX (1) MXPA06014698A (it)
PL (1) PL1763339T3 (it)
PT (1) PT1763339E (it)
RS (1) RS50581B (it)
SI (1) SI1763339T1 (it)
WO (1) WO2006003043A1 (it)
ZA (1) ZA200610577B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP3714878B1 (en) † 2007-07-06 2022-01-19 Lupin Limited Pharmaceutical compositions of rifaximin
US20100239682A1 (en) * 2007-09-17 2010-09-23 Antoine Andremont Colonic delivery of antimicrobial agents
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
WO2010081079A2 (en) 2009-01-12 2010-07-15 Biokier Inc. Composition and method for treatment of diabetes
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
JP2013505936A (ja) 2009-09-23 2013-02-21 バイオキアー・インコーポレイテッド 糖尿病の治療のための組成物および方法
WO2012016707A2 (en) * 2010-08-06 2012-02-09 Ratiopharm Gmbh Oral dosage form for the modified release of dimebolin
WO2012075015A2 (en) * 2010-11-29 2012-06-07 Dr. Reddy's Laboratories Ltd. Oral metronidazole pharmaceutical compositions
MX2020004706A (es) * 2017-11-10 2020-09-07 Cosmo Technologies Ltd Composiciones orales de rifamicina sv.
IT202000005782A1 (it) 2020-03-18 2021-09-18 Dpl Pharma S P A Formulazioni farmaceutiche a rilascio controllato per il trattamento di infezioni intestinali

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE458505B (sv) * 1979-07-10 1989-04-10 Lepetit Spa Anvaendningen av rifamycin sv och salter daerav foer framstaellning av en beredning foer behandling av reumatoid artrit samt vissa av salterna och deras framstaellning
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
IT1230576B (it) 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
IT1260505B (it) 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
CN1097306A (zh) * 1993-07-12 1995-01-18 中国医科大学第二临床学院 复方抗炎栓剂
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6245351B1 (en) 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
US5985823A (en) 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
NZ501251A (en) * 1997-07-01 2001-09-28 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
DK1183014T3 (da) 1999-06-14 2004-02-09 Cosmo Spa Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
JP4393098B2 (ja) 2002-06-21 2010-01-06 独立行政法人科学技術振興機構 アンサマイシン系抗生物質の新規用途及び新規血管新生抑制物質のスクリーニング方法
CN1201736C (zh) * 2002-07-19 2005-05-18 安徽省药物研究所 甲硝唑结肠定位缓释制剂
DE60323380D1 (de) 2002-08-26 2008-10-16 Sla Pharma Ag Topische formulierung mit mindestens 10% metronidazol in entfärbtem petrolatum und ihre verwendung im anal- und rektalbereich
WO2005030173A1 (en) * 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited Colon-specific drug delivery using interpolymer complexations

Also Published As

Publication number Publication date
CA2628005A1 (en) 2006-01-12
FIC20190031I1 (fi) 2019-05-28
HRP20080252T3 (en) 2008-07-31
DK1763339T3 (da) 2008-08-11
CA2569683C (en) 2012-04-03
KR101157486B1 (ko) 2012-07-09
US8529945B2 (en) 2013-09-10
US8486446B2 (en) 2013-07-16
JP2008503540A (ja) 2008-02-07
US20140370093A1 (en) 2014-12-18
EP1763339A1 (en) 2007-03-21
CN101317826A (zh) 2008-12-10
SI1763339T1 (sl) 2008-08-31
US20210093576A1 (en) 2021-04-01
CY1108196T1 (el) 2014-02-12
PL1763339T3 (pl) 2008-10-31
US20080233193A1 (en) 2008-09-25
RS50581B (sr) 2010-05-07
ATE392889T1 (de) 2008-05-15
US8263120B2 (en) 2012-09-11
DE602005006278T2 (de) 2009-10-08
EP1894560A1 (en) 2008-03-05
PT1763339E (pt) 2008-06-19
DE602005006278D1 (de) 2008-06-05
US20120316229A1 (en) 2012-12-13
US20190192441A1 (en) 2019-06-27
US20120207834A1 (en) 2012-08-16
HUS1900037I1 (hu) 2019-07-29
ES2303255T3 (es) 2008-08-01
WO2006003043A1 (en) 2006-01-12
JP2008163038A (ja) 2008-07-17
ZA200610577B (en) 2008-07-30
EP1763339B1 (en) 2008-04-23
US20070248664A1 (en) 2007-10-25
KR20080059337A (ko) 2008-06-26
MXPA06014698A (es) 2007-03-26
US20120316228A1 (en) 2012-12-13
CN1976685B (zh) 2011-05-18
JP5026262B2 (ja) 2012-09-12
CN1976685A (zh) 2007-06-06
KR20070028441A (ko) 2007-03-12
US20130004569A1 (en) 2013-01-03
US8741948B2 (en) 2014-06-03
CA2569683A1 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
HUS1900037I1 (hu) Orális mikrobaellenes gyógyszerészeti kompozíciók
MY150958A (en) Compounds for the treatment of multi-drug resistant bacterial infections
ATE537828T1 (de) Psychotropes mittel und nahrungsmittel zur förderung der gesundheit enthaltend neferin
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
DE602005011240D1 (de) Landwirtschaftliche desinfizierende Zusammensetzung enthaltend Hypochlorsäure und Streumittel
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
ATE492272T1 (de) Therapeutische antimikrobielle zusammensetzungen und methoden
ATE415968T1 (de) 3,11b-cis-dihydrotetrabanezin zur behandlung von schizophrenie und anderen psychosen
DE602004008105D1 (de) 42-o-alkoxyalkylrapamycinderivate und diese enthaltende zusammensetzungen
MX2008001917A (es) Mezclas insecticidas, sinergicas.
ATE355065T1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
ATE272397T1 (de) Selektive antibakterielle zusammensetzungen
WO2009095423A3 (en) Oral care composition for combating dentine hypersensitivity
ATE511512T1 (de) Olanzapinpamoat-dihydrat
ITBO20050416A1 (it) Composizione per la cura e/o la prevenzione di attacchi da parte di agenti biologici
EP2801359A3 (en) The use of nicotine for the treatment of sepsis in humans caused by antibiotic
DK1827496T3 (da) Orale behandlingssammensætninger indeholde et antiadhæsionsmiddel, et antibakterielt middel og en inkompatibel forbindelse
DK1666473T3 (da) Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens
EE200800065A (et) Prasoloprimidinoonhendit sisaldav toimeaine eesn„„rmesuurenemuse „rahoidmiseks ja raviks
DE112005001443T5 (de) Mittel gegen Tuberkulose zur Behandlung und Prophylaxe
RU2006144987A (ru) Лечебная композиция "левоксиколь"
CL2004000753A1 (es) Compuestos derivados de oxazolidinona y/o isoxazolina, composicion farmaceutica, procedimiento de preparacion, utiles como antibacterianos.
RU2006139609A (ru) Железосодержащее средство для профилактики и лечения анемии у животных